Vitalhub Corp. (TSX:VHI)
Canada · Delayed Price · Currency is CAD | Market Cap | 451.04M -26.6% |
| Revenue (ttm) | 119.20M +58.9% |
| Net Income | 7.30M +157.0% |
| EPS | 0.12 +170.3% |
| Shares Out | 63.26M |
| PE Ratio | 59.27 |
| Forward PE | 28.22 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 224,565 |
| Open | 7.09 |
| Previous Close | 7.10 |
| Day's Range | 6.98 - 7.24 |
| 52-Week Range | 6.62 - 14.64 |
| Beta | 0.77 |
| Analysts | Buy |
| Price Target | 12.33 (+72.93%) |
| Earnings Date | Aug 6, 2026 |
About Vitalhub
Vitalhub Corp., together with its subsidiaries, provides technology and software solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. The company offers patient flow, operational visibility, and patient journey optimization solutions for hospital and integrated health environments, including SHREWD, Intouch with Health, Strata Health, MedCurrent, Beautiful Information, My Pathway, BookWise Solutions, Jayex Acute, MCAP, and Oculys. It also provides electr... [Read more]
Financial Performance
In 2025, Vitalhub's revenue was 108.97 million, an increase of 58.86% compared to the previous year's 68.59 million. Earnings were 6.11 million, an increase of 103.76%.
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for VHI stock is "Buy." The 12-month stock price target is $12.33, which is an increase of 72.93% from the latest price.
News
Vitalhub Corp Annual Shareholders Meeting Transcript
Vitalhub Corp Annual Shareholders Meeting Transcript
VitalHub Announces Results of Annual General Meeting of Shareholders
TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results from its annual general meeting of shareholders held ...
VitalHub Announces Deployments of Referral Management Solutions
TORONTO, June 16, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health, a VitalHub company, has executed agreements to imple...
Vitalhub Earnings Call Transcript: Q1 2026
Reported 47% year-over-year revenue growth and 11% organic ARR growth, with improved margins and strong cash position. Novari led growth, AI initiatives advanced, and board changes were made. Confident in double-digit ARR growth for 2026.
Vitalhub Earnings release: Q1 2026
Vitalhub released its Q1 2026 earnings on May 8, 2026, summarizing the period's financial results.
Vitalhub Registration statement: Q1 2026
Vitalhub filed a registration statement on May 8, 2026, providing details about a securities offering with the SEC.
Vitalhub Registration statement: Q1 2026
Vitalhub filed a registration statement on May 8, 2026, providing details about a securities offering with the SEC.
VitalHub Reports First Quarter 2026 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 34% YoY to $99.1 million Total Revenue up 47% YoY to $31.9 million Adjusted EBITDA⁽¹⁾ up 42% YoY to $8.0 million TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalh...
VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today proposed changes to its Board of Directors (the “Board”) in connection wi...
VitalHub Announces Q1 2026 Conference Call Date
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- VitalHub Corp. (TSX:VHI) (OTCQX:VHIBF) (the "Company" or "VitalHub") announced today that it will release financial results for the first quarter 2026 ended...
Vitalhub price target lowered to C$11 from C$13.50 at Stifel
Stifel lowered the firm’s price target on Vitalhub (VHIBF) to C$11 from C$13.50 and keeps a Buy rating on the shares.
Vitalhub price target lowered to C$11 from C$12 at RBC Capital
RBC Capital lowered the firm’s price target on Vitalhub (VHIBF) to C$11 from C$12 and keeps an Outperform rating on the shares.
Vitalhub Earnings Call Transcript: Q4 2025
Full-year revenue surpassed CAD 100 million with 10% ARR growth and strong Q4 results. Integration of recent acquisitions is driving cost synergies and cross-selling, while AI initiatives are expected to contribute to revenue from mid-2026. Cash position remains robust, supporting further M&A.
Vitalhub Earnings release: Q4 2025
Vitalhub released its Q4 2025 earnings on March 19, 2026, summarizing the period's financial results.
Vitalhub Registration statement: Q4 2025
Vitalhub filed a registration statement on March 19, 2026, providing details about a securities offering with the SEC.
Vitalhub Registration statement: Q4 2025
Vitalhub filed a registration statement on March 19, 2026, providing details about a securities offering with the SEC.
VitalHub Reports Fourth Quarter 2025 Results
Annual Recurring Revenue (“ARR”)⁽¹⁾ up 35% YoY to $96.1 million Total Revenue up 52% YoY to $31.4 million Adjusted EBITDA⁽¹⁾ up 47% YoY to $7.4 million
VitalHub Announces Updated Date for Fourth Quarter and Annual 2025 Results
TORONTO, March 12, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that it has updated the date for the release of its financial results f...
Vitalhub announces Novari Health AI-enhanced referral management deployment
Vitalhub (VHIBF) announced that Novari Health, a VitalHub company, and Niagara Health are building upon an existing partnership by implementing Novari’s Medical Imaging Requisition Management and eReq...
VitalHub Announces Novari Health AI-Enhanced Referral Management Deployment
TORONTO, March 09, 2026 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today that Novari Health (“Novari”), a VitalHub company, and Niagara Health a...
Vitalhub price target lowered to C$12 from C$15 at Scotiabank
Scotiabank lowered the firm’s price target on Vitalhub (VHIBF) to C$12 from C$15 and keeps an Outperform rating on the shares.
Vitalhub Transcript: 2nd Annual Lytham Partners Healthcare Investor Summit
A healthcare IT vendor serving government-funded systems globally, the company drives growth through organic expansion and strategic acquisitions, with 80% recurring revenue and a strong cash position. AI integration and further M&A are expected to boost ARR and margins by 2026.
Vitalhub Slides: Investor presentation
Vitalhub has posted slides in relation to its latest quarterly earnings report, which was published on November 10, 2025.
Vitalhub Earnings Call Transcript: Q3 2025
Q3 revenue nearly doubled year-over-year, driven by acquisitions and strong recurring revenue. Integration and cost reduction efforts are ongoing, with a focus on restoring EBITDA margins and leveraging AI for future growth.
Vitalhub Earnings release: Q3 2025
Vitalhub released its Q3 2025 earnings on November 7, 2025, summarizing the period's financial results.